GLP 1 News and Research

RSS
MCM purchases Provantis preclinical software solution

MCM purchases Provantis preclinical software solution

MicroConstants acquires access to new nanosizing technology

MicroConstants acquires access to new nanosizing technology

ILS selects Provantis for fully automating toxicology data acquisition, analysis and reporting processes

ILS selects Provantis for fully automating toxicology data acquisition, analysis and reporting processes

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

WuXi PharmaTech, JANSSEN division announce collaboration for preclinical services

WuXi PharmaTech, JANSSEN division announce collaboration for preclinical services

Using genetic engineering techniques in pigs, scientists create new model of diabetes

Using genetic engineering techniques in pigs, scientists create new model of diabetes

ADMET tester Absorption Systems joins Society of Toxicology as Affiliate

ADMET tester Absorption Systems joins Society of Toxicology as Affiliate

Marcadia Biotech commences Phase 1 clinical trial of MAR701 for type 2 diabetes

Marcadia Biotech commences Phase 1 clinical trial of MAR701 for type 2 diabetes

Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma

Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma

Ipsen reports consolidated group sales of €1,032.8M for 2009

Ipsen reports consolidated group sales of €1,032.8M for 2009

MPI Research lauds FDA's current guidance on abuse potential of drugs

MPI Research lauds FDA's current guidance on abuse potential of drugs

FDA approves Victoza to treat type 2 diabetes in some adults

FDA approves Victoza to treat type 2 diabetes in some adults

FDA approves Novo Nordisk's Victoza for type 2 diabetes

FDA approves Novo Nordisk's Victoza for type 2 diabetes

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Pharmaron Holdings acquires Bridge Laboratories China

Pharmaron Holdings acquires Bridge Laboratories China

LAB Research completes research and development program that involves pulmonary monitoring system

LAB Research completes research and development program that involves pulmonary monitoring system

Liraglutide FDA feedback expected within weeks, says Novo Nordisk

Liraglutide FDA feedback expected within weeks, says Novo Nordisk

CSC completes a Series B financing round

CSC completes a Series B financing round

KVCI completes acquisition of former AAIPharma bioanalytical division

KVCI completes acquisition of former AAIPharma bioanalytical division